Meeting
2014 ASCO Annual Meeting
Correlation between risk benefit index and uptake of breast cancer chemoprevention.
Authors
Parijatham S. Sivasubramanian
Columbia University Medical Center, New York, NY
Parijatham S. Sivasubramanian , Katherine D. Crew , Kevin Kalinsky , Dawn L. Hershman , Matthew A. Maurer , Heather Greenlee , Laura L. Reimers , Mary Beth Terry
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Cancer Prevention
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1568)
DOI
10.1200/jco.2014.32.15_suppl.1568
Abstract #
1568
Poster Bd #
350
Abstract Disclosures
Similar Posters
Poster
2012 Breast Cancer Symposium
A program to increase use of chemoprevention for women with high-risk breast lesions.
First Author: Constance Roche
Poster
2013 ASCO Annual Meeting
Clinical experience with exemestane in postmenopausal women at increased risk of breast cancer.
First Author: Mia Sorkin
Poster
2023 ASCO Annual Meeting
Influence of hormone therapy timing intake on disease free survival (DFS) for patients with high-risk early breast cancer: Results of the UCBG-UNIRAD phase III randomized trial.
First Author: Sylvie Giacchetti
Poster
2023 ASCO Annual Meeting
Evolving adjuvant estrogen therapy prescribing among breast oncology workforce.
First Author: Kayla Polcari